Cargando…

Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR

BACKGROUND: Gastric cancer is the fourth most common cancer and the second most deadly cancer worldwide. Study on molecular mechanisms of carcinogenesis will play a significant role in diagnosing and treating gastric cancer. Metabolic profiling may offer the opportunity to understand the molecular m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huijuan, Zhang, Hailong, Deng, Pengchi, Liu, Chunqi, Li, Dandan, Jie, Hui, Zhang, Hu, Zhou, Zongguang, Zhao, Ying-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928316/
https://www.ncbi.nlm.nih.gov/pubmed/27356757
http://dx.doi.org/10.1186/s12885-016-2356-4
_version_ 1782440416389365760
author Wang, Huijuan
Zhang, Hailong
Deng, Pengchi
Liu, Chunqi
Li, Dandan
Jie, Hui
Zhang, Hu
Zhou, Zongguang
Zhao, Ying-Lan
author_facet Wang, Huijuan
Zhang, Hailong
Deng, Pengchi
Liu, Chunqi
Li, Dandan
Jie, Hui
Zhang, Hu
Zhou, Zongguang
Zhao, Ying-Lan
author_sort Wang, Huijuan
collection PubMed
description BACKGROUND: Gastric cancer is the fourth most common cancer and the second most deadly cancer worldwide. Study on molecular mechanisms of carcinogenesis will play a significant role in diagnosing and treating gastric cancer. Metabolic profiling may offer the opportunity to understand the molecular mechanism of carcinogenesis and help to identify the potential biomarkers for the early diagnosis of gastric cancer. METHODS: In this study, we reported the metabolic profiling of tissue samples on a large cohort of human gastric cancer subjects (n = 125) and normal controls (n = 54) based on (1)H nuclear magnetic resonance ((1)H NMR) together with multivariate statistical analyses (PCA, PLS-DA, OPLS-DA and ROC curve). RESULTS: The OPLS-DA model showed adequate discrimination between cancer tissues and normal controls, and meanwhile, the model excellently discriminated the stage-related of tissue samples (stage I, 30; stage II, 46; stage III, 37; stage IV, 12) and normal controls. A total of 48 endogenous distinguishing metabolites (VIP > 1 and p < 0.05) were identified, 13 of which were changed with the progression of gastric cancer. These modified metabolites revealed disturbance of glycolysis, glutaminolysis, TCA, amino acids and choline metabolism, which were correlated with the occurrence and development of human gastric cancer. The receiver operating characteristic diagnostic AUC of OPLS-DA model between cancer tissues and normal controls was 0.945. And the ROC curves among different stages cancer subjects and normal controls were gradually improved, the corresponding AUC values were 0.952, 0.994, 0.998 and 0.999, demonstrating the robust diagnostic power of this metabolic profiling approach. CONCLUSION: As far as we know, the present study firstly identified the differential metabolites in various stages of gastric cancer tissues. And the AUC values were relatively high. So these results suggest that the metabolic profiling of gastric cancer tissues has great potential in detecting this disease and helping to understand its underlying metabolic mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2356-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4928316
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49283162016-06-30 Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR Wang, Huijuan Zhang, Hailong Deng, Pengchi Liu, Chunqi Li, Dandan Jie, Hui Zhang, Hu Zhou, Zongguang Zhao, Ying-Lan BMC Cancer Research Article BACKGROUND: Gastric cancer is the fourth most common cancer and the second most deadly cancer worldwide. Study on molecular mechanisms of carcinogenesis will play a significant role in diagnosing and treating gastric cancer. Metabolic profiling may offer the opportunity to understand the molecular mechanism of carcinogenesis and help to identify the potential biomarkers for the early diagnosis of gastric cancer. METHODS: In this study, we reported the metabolic profiling of tissue samples on a large cohort of human gastric cancer subjects (n = 125) and normal controls (n = 54) based on (1)H nuclear magnetic resonance ((1)H NMR) together with multivariate statistical analyses (PCA, PLS-DA, OPLS-DA and ROC curve). RESULTS: The OPLS-DA model showed adequate discrimination between cancer tissues and normal controls, and meanwhile, the model excellently discriminated the stage-related of tissue samples (stage I, 30; stage II, 46; stage III, 37; stage IV, 12) and normal controls. A total of 48 endogenous distinguishing metabolites (VIP > 1 and p < 0.05) were identified, 13 of which were changed with the progression of gastric cancer. These modified metabolites revealed disturbance of glycolysis, glutaminolysis, TCA, amino acids and choline metabolism, which were correlated with the occurrence and development of human gastric cancer. The receiver operating characteristic diagnostic AUC of OPLS-DA model between cancer tissues and normal controls was 0.945. And the ROC curves among different stages cancer subjects and normal controls were gradually improved, the corresponding AUC values were 0.952, 0.994, 0.998 and 0.999, demonstrating the robust diagnostic power of this metabolic profiling approach. CONCLUSION: As far as we know, the present study firstly identified the differential metabolites in various stages of gastric cancer tissues. And the AUC values were relatively high. So these results suggest that the metabolic profiling of gastric cancer tissues has great potential in detecting this disease and helping to understand its underlying metabolic mechanisms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2356-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-29 /pmc/articles/PMC4928316/ /pubmed/27356757 http://dx.doi.org/10.1186/s12885-016-2356-4 Text en © Wang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Huijuan
Zhang, Hailong
Deng, Pengchi
Liu, Chunqi
Li, Dandan
Jie, Hui
Zhang, Hu
Zhou, Zongguang
Zhao, Ying-Lan
Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR
title Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR
title_full Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR
title_fullStr Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR
title_full_unstemmed Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR
title_short Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR
title_sort tissue metabolic profiling of human gastric cancer assessed by (1)h nmr
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928316/
https://www.ncbi.nlm.nih.gov/pubmed/27356757
http://dx.doi.org/10.1186/s12885-016-2356-4
work_keys_str_mv AT wanghuijuan tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT zhanghailong tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT dengpengchi tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT liuchunqi tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT lidandan tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT jiehui tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT zhanghu tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT zhouzongguang tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr
AT zhaoyinglan tissuemetabolicprofilingofhumangastriccancerassessedby1hnmr